Cytophage Technologies Ltd. (TSE:CYTO)
TSXV:CYTO
Canadian Market

Cytophage Technologies Ltd. (CYTO) Income Statement

2 Followers

Cytophage Technologies Ltd. Income Statement

Last quarter (Q ), Cytophage Technologies Ltd.'s total revenue was C$―, a decrease of ― from the same quarter last year. In Q, Cytophage Technologies Ltd.'s net income was C$-4.28M. See Cytophage Technologies Ltd.’s key income statements, including revenue, expenses, profit, and income.
Income Statement
TTM
Dec 23Dec 22
Total Revenue
---
Cost of Revenue
---
Gross Profit
---
Operating Expense
C$ 4.40MC$ 109.64KC$ 725.94K
Operating Income
C$ -4.40MC$ -109.64KC$ -725.94K
Net Non Operating Interest Income Expense
C$ 206.90KC$ 241.42KC$ 86.04K
Other Income Expense
C$ 109.50KC$ 109.77KC$ 66.31K
Pretax Income
C$ -4.30MC$ 22.01KC$ -706.21K
Tax Provision
---
Earnings From Equity Interest Net Of Tax
---
Net Income Common Stockholders
C$ -3.30MC$ 22.01KC$ -706.21K
Basic EPS
C$ -0.05--
Diluted EPS
C$ -0.06--
Basic Average Shares
C$ 74.78MC$ 25.00M-
Diluted Average Shares
C$ 79.14MC$ 26.09M-
Dividend Per Share
---
Total Operating Income As Reported
---
Reported Normalized Basic E P S
---
Reported Normalized Diluted E P S
---
Rent Expense Supplemental
---
Total Expenses
C$ 99.59K-C$ 725.94K
Net Income From Continuing And Discontinued Operation
C$ -3.30MC$ 22.01KC$ -706.21K
Normalized Income
C$ -4.26MC$ 16.18KC$ -519.06K
Interest Expense
---
EBIT
C$ -3.27MC$ 22.01KC$ -706.21K
EBITDA
C$ -3.09MC$ 22.01KC$ -706.21K
Currency in CAD

Cytophage Technologies Ltd. Earnings and Revenue History

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis